Safety and Survival Outcomes in the Non-Interventional Post-Authorization Study of Patients Treated with Pomalidomide for Relapsed and Refractory Multiple Myeloma: A Sub-Analysis of Patients with Prior Triple Class Exposure

Karthik Ramasamy; Niels Abildgaard; Marie-Christiane  Vekemans; Barbara Gamberi; Angel  Ramirez Payer; Gillian  Millar; Annalisa Ansaloni; Margaret  Atiba-Davies; David Bernasconi; Torben Plesner; Sujith   Dhanasiri

doi:10.1182/blood-2022-162529

Safety and Survival Outcomes in the Non-Interventional Post-Authorization Study of Patients Treated with Pomalidomide for Relapsed and Refractory Multiple Myeloma: A Sub-Analysis of Patients with Prior Triple Class Exposure

Karthik Ramasamy^*, Niels Abildgaard, Marie-Christiane Vekemans, Barbara Gamberi, Angel Ramirez Payer, Gillian Millar, Annalisa Ansaloni, Margaret Atiba-Davies, David Bernasconi, Torben Plesner, Sujith Dhanasiri

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Blood
Vol/bind	140
Udgave nummer	Suppl. 1
Sider (fra-til)	10000–10001
ISSN	0006-4971
DOI	https://doi.org/10.1182/blood-2022-162529
Status	Udgivet - dec. 2022
Begivenhed	64TH ASH ANNUAL MEETING & EXPOSITION - New Orleans, USA Varighed: 10. dec. 2022 → 13. dec. 2022

Konference

Konference	64TH ASH ANNUAL MEETING & EXPOSITION
Land/Område	USA
By	New Orleans
Periode	10/12/2022 → 13/12/2022

Dokumenter og links

10.1182/blood-2022-162529

https://ashpublications.org/blood/article/140/Supplement%201/10000/490519/Safety-and-Survival-Outcomes-in-the-Non

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Ramasamy, K., Abildgaard, N., Vekemans, M.-C., Gamberi, B., Ramirez Payer, A., Millar, G., Ansaloni, A., Atiba-Davies, M., Bernasconi, D., Plesner, T., & Dhanasiri, S. (2022). Safety and Survival Outcomes in the Non-Interventional Post-Authorization Study of Patients Treated with Pomalidomide for Relapsed and Refractory Multiple Myeloma: A Sub-Analysis of Patients with Prior Triple Class Exposure. Blood, 140(Suppl. 1), 10000–10001. https://doi.org/10.1182/blood-2022-162529

@article{4bc9c1820cbe426993044cf6c0e48215,

title = "Safety and Survival Outcomes in the Non-Interventional Post-Authorization Study of Patients Treated with Pomalidomide for Relapsed and Refractory Multiple Myeloma: A Sub-Analysis of Patients with Prior Triple Class Exposure",

author = "Karthik Ramasamy and Niels Abildgaard and Marie-Christiane Vekemans and Barbara Gamberi and {Ramirez Payer}, Angel and Gillian Millar and Annalisa Ansaloni and Margaret Atiba-Davies and David Bernasconi and Torben Plesner and Sujith Dhanasiri",

year = "2022",

month = dec,

doi = "10.1182/blood-2022-162529",

language = "English",

volume = "140",

pages = "10000–10001",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier",

number = "Suppl. 1",

note = "64TH ASH ANNUAL MEETING & EXPOSITION ; Conference date: 10-12-2022 Through 13-12-2022",

}

Ramasamy, K, Abildgaard, N, Vekemans, M-C, Gamberi, B, Ramirez Payer, A, Millar, G, Ansaloni, A, Atiba-Davies, M, Bernasconi, D, Plesner, T & Dhanasiri, S 2022, 'Safety and Survival Outcomes in the Non-Interventional Post-Authorization Study of Patients Treated with Pomalidomide for Relapsed and Refractory Multiple Myeloma: A Sub-Analysis of Patients with Prior Triple Class Exposure', Blood, bind 140, nr. Suppl. 1, s. 10000–10001. https://doi.org/10.1182/blood-2022-162529

Safety and Survival Outcomes in the Non-Interventional Post-Authorization Study of Patients Treated with Pomalidomide for Relapsed and Refractory Multiple Myeloma: A Sub-Analysis of Patients with Prior Triple Class Exposure. / Ramasamy, Karthik; Abildgaard, Niels; Vekemans, Marie-Christiane et al.
I: Blood, Bind 140, Nr. Suppl. 1, 12.2022, s. 10000–10001.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Safety and Survival Outcomes in the Non-Interventional Post-Authorization Study of Patients Treated with Pomalidomide for Relapsed and Refractory Multiple Myeloma: A Sub-Analysis of Patients with Prior Triple Class Exposure

AU - Ramasamy, Karthik

AU - Abildgaard, Niels

AU - Vekemans, Marie-Christiane

AU - Gamberi, Barbara

AU - Ramirez Payer, Angel

AU - Millar, Gillian

AU - Ansaloni, Annalisa

AU - Atiba-Davies, Margaret

AU - Bernasconi, David

AU - Plesner, Torben

AU - Dhanasiri, Sujith

PY - 2022/12

Y1 - 2022/12

U2 - 10.1182/blood-2022-162529

DO - 10.1182/blood-2022-162529

M3 - Conference abstract in journal

SN - 0006-4971

VL - 140

SP - 10000

EP - 10001

JO - Blood

JF - Blood

IS - Suppl. 1

T2 - 64TH ASH ANNUAL MEETING & EXPOSITION

Y2 - 10 December 2022 through 13 December 2022

ER -

Ramasamy K, Abildgaard N, Vekemans MC, Gamberi B, Ramirez Payer A, Millar G et al. Safety and Survival Outcomes in the Non-Interventional Post-Authorization Study of Patients Treated with Pomalidomide for Relapsed and Refractory Multiple Myeloma: A Sub-Analysis of Patients with Prior Triple Class Exposure. Blood. 2022 dec.;140(Suppl. 1):10000–10001. doi: 10.1182/blood-2022-162529